Singapore markets closed
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,070.55 +59.95 (+1.20%) Dow
38,503.69 +263.71 (+0.69%) Nasdaq
15,696.64 +245.33 (+1.59%) Bitcoin USD
66,419.86 +128.87 (+0.19%) CMC Crypto 200
1,433.60 +9.50 (+0.67%)
BioMarin Pharmaceutical Inc. (0HNC.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 07:09PM BST. Market open.
| Previous close | 89.32 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 5,967 |
| Market cap | 167.836M |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 4.29 |
| EPS (TTM) | 0.22 |
| Earnings date | 24 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksIs a Surprise Coming for BioMarin (BMRN) This Earnings Season?
BioMarin (BMRN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ZacksAstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Sales of AstraZeneca's (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new indications.
ZacksGear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for BioMarin (BMRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.